Adamantane derivatives for the treatment of filovirus infection
US12240857B2 · kind B2 · utility
0Cited by
39References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2018 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Jul 12, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of structural Formula I were developed for the treatment of infections by filoviruses including Ebolavirus and Marburgvirus, wherein, R1, R2, R3, X and Y are defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.